ArticleAntioxidants (Basel, Switzerland)2025

c-Abl/TFEB Pathway Activation as a Common Pathogenic Mechanism in Lysosomal Storage Diseases: Therapeutic Potential of c-Abl Inhibitors.

Miguel V Guerra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.